<DOC>
	<DOC>NCT02637076</DOC>
	<brief_summary>The overall aim is to establish whether the drug Xyrem速 has an action on the brain dopamine system in patients with narcolepsy. Trial Objective is to establish, using positron emission tomography (PET), in Xyrem速-na誰ve narcolepsy with cataplexy patients, whether a single dose of Xyrem速 causes changes in striatal binding of 11C-raclopride and 11C-DTBZ that would suggest altered activity of brain dopamine neurones.</brief_summary>
	<brief_title>Xyrem and Brain Dopamine in Narcolepsy</brief_title>
	<detailed_description />
	<mesh_term>Narcolepsy</mesh_term>
	<mesh_term>Cataplexy</mesh_term>
	<mesh_term>Dopamine</mesh_term>
	<mesh_term>Dopamine Agents</mesh_term>
	<mesh_term>Sodium Oxybate</mesh_term>
	<criteria>narcolepsy with cataplexy significant unstable or uncontrolled medical/psychiatric disease significant history of head trauma/surgery or seizure disorder radiation exposure exceeding 20mSv in last 12 months pregnancy substance abuse/dependence (including alcohol)</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Xyrem</keyword>
	<keyword>narcolepsy with cataplexy</keyword>
	<keyword>positron emission tomography</keyword>
	<keyword>dopamine</keyword>
</DOC>